Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CHFS NASDAQ:DRAD OTCMKTS:NIMU OTCMKTS:NXNN OTCMKTS:VASO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHFSNuwellis$7.45+0.9%$4.79$4.86▼$37.50$44.95M1.55467,323 shs31,664 shsDRADDigirad$1.94-1.0%$3.58$1.99▼$8.84$9.23M0.18485,592 shs9,477 shsNIMUNon-Invasive Monitoring Systems$0.00$0.01$0.00▼$0.02$630K0.974,069 shs200 shsNXNNNexeon Medsystems$0.00$0.00▼$0.00N/A6.98300 shs200 shsVASOVaso$0.12-3.1%$0.13$0.11▼$0.32$22.14M1.5333,864 shs21,381 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHFSNuwellis-6.58%+3,262.19%+3,108.70%+686.78%+93.70%DRADDigirad0.00%+0.51%-6.67%+0.10%-49.87%NIMUNon-Invasive Monitoring Systems0.00%0.00%-31.67%+2.50%-79.29%NXNNNexeon Medsystems0.00%0.00%0.00%0.00%0.00%VASOVaso+4.13%+0.48%-3.08%-6.46%-46.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHFSNuwellisN/AN/AN/AN/AN/AN/AN/AN/ADRADDigiradN/AN/AN/AN/AN/AN/AN/AN/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/AN/AN/AVASOVaso0.4342 of 5 stars0.03.00.00.00.01.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHFSNuwellis 0.00N/AN/AN/ADRADDigirad 0.00N/AN/AN/ANIMUNon-Invasive Monitoring Systems 0.00N/AN/AN/ANXNNNexeon Medsystems 0.00N/AN/AN/AVASOVaso 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHFSNuwellis$5.51M8.16N/AN/A$12.79 per share0.58DRADDigirad$114.18M0.08$2.81 per share0.69$10.30 per share0.19NIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AN/AVASOVaso$86.77M0.25$0.01 per share11.97$0.16 per share0.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHFSNuwellis-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/ADRADDigirad-$4.63M-$0.35N/A∞N/A-5.32%-3.75%-0.85%N/ANIMUNon-Invasive Monitoring Systems-$110KN/A0.00∞N/AN/AN/A-251.43%N/ANXNNNexeon MedsystemsN/AN/A0.00N/AN/AN/AN/AN/AN/AVASOVaso$950KN/A0.00∞N/A1.20%3.93%1.37%8/12/2025 (Estimated)Latest VASO, DRAD, NIMU, CHFS, and NXNN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025VASOVasoN/A-$0.01N/A-$0.01N/A$19.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHFSNuwellisN/AN/AN/AN/AN/ADRADDigirad$2.20113.40%N/AN/A N/ANIMUNon-Invasive Monitoring SystemsN/AN/AN/AN/AN/ANXNNNexeon MedsystemsN/AN/AN/AN/AN/AVASOVasoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHFSNuwellisN/A6.875.97DRADDigirad0.881.270.91NIMUNon-Invasive Monitoring SystemsN/A0.030.03NXNNNexeon MedsystemsN/AN/AN/AVASOVasoN/A1.521.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHFSNuwellis65.06%DRADDigirad11.38%NIMUNon-Invasive Monitoring Systems0.12%NXNNNexeon MedsystemsN/AVASOVasoN/AInsider OwnershipCompanyInsider OwnershipCHFSNuwellis0.60%DRADDigirad12.49%NIMUNon-Invasive Monitoring Systems28.80%NXNNNexeon Medsystems61.19%VASOVaso44.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHFSNuwellis666.04 millionN/ANot OptionableDRADDigirad6184.76 millionN/ANot OptionableNIMUNon-Invasive Monitoring Systems3154.81 million110.23 millionNot OptionableNXNNNexeon Medsystems60N/AN/ANot OptionableVASOVaso260175.74 million97.54 millionNot OptionableVASO, DRAD, NIMU, CHFS, and NXNN HeadlinesRecent News About These CompaniesVaso (OTCMKTS:VASO) Stock Passes Above 200 Day Moving Average - Here's What HappenedJuly 8 at 4:15 AM | americanbankingnews.comLevel of physical activity tied to less pain, blood viscosity in SCD: StudyJune 26, 2025 | sicklecellanemianews.comSCorn in a Cup (Elote en Vaso)June 7, 2025 | msn.comOral inhibitor rilzabrutinib granted FDA orphan drug status for SCDJune 5, 2025 | sicklecellanemianews.comSUS FDA grants orphan drug designation to Sanofi’s rilzabrutinib to treat sickle cell diseaseJune 5, 2025 | pharmabiz.comPSanofi Rilzabrutinib gets USFDA orphan drug designation for sickle cell diseaseJune 4, 2025 | medicaldialogues.inMPress Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell diseaseJune 3, 2025 | taiwannews.com.twTSickle cell disease and knee joint pain: Why steriods aren’t always the best optionMay 30, 2025 | punchng.comPVaso Corporation Registered ShsMay 20, 2025 | markets.businessinsider.comVaso Stock Slips Post Q1 Earnings Despite Record Revenue GrowthMay 20, 2025 | zacks.comVaso Corporation Announces Financial Results for First Quarter of 2025May 15, 2025 | globenewswire.comNew tapas and wine bar to open in Nottingham from the team behind MesaMay 6, 2025 | msn.comHe compared him to Justin Bieber, but he got what he deserved in the ringApril 24, 2025 | msn.comThe Zacks Analyst Blog Highlights Apple, Philip Morris International, Sony and VasoApril 21, 2025 | uk.finance.yahoo.comC-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell DiseaseApril 18, 2025 | rheumatologyadvisor.comRTop Analyst Reports for Apple, Philip Morris & SonyApril 17, 2025 | finance.yahoo.comShake up your Monday: VASO hosts an electrifying cocktail showdown with top bartendersApril 17, 2025 | myfox28columbus.comMInflammation during menstrual cycle may trigger VOEs: StudyApril 15, 2025 | sicklecellanemianews.comSDangerous 'crises' in sickle cell disease may be amplified by menstrual cycleApril 14, 2025 | msn.comVASO Stock Rises Post Q4 Revenue Growth and Solid Segment GainsApril 7, 2025 | zacks.comMedia Sentiment Over TimeVASO, DRAD, NIMU, CHFS, and NXNN Company DescriptionsNuwellis NASDAQ:CHFSNuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.Digirad NASDAQ:DRADDigirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.Non-Invasive Monitoring Systems OTCMKTS:NIMU$0.0041 0.00 (0.00%) As of 07/9/2025 01:38 PM EasternNon-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.Nexeon Medsystems OTCMKTS:NXNNNexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.Vaso OTCMKTS:VASO$0.12 0.00 (-3.10%) As of 03:13 PM EasternVaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Plug Power’s 20% Surge Signals New Commercial Growth Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
